cGMP Violations Lead to Warning Letter for Brazilian Company

Drug Industry Daily
A A
Mappel Industria, a Brazil-based company received a warning letter from the FDA due to significant violations of cGMP regulations for finished pharmaceuticals.

To View This Article:

Login

Subscribe To Drug Industry Daily